Which anesthetic should be used in the treatment of refractory status epilepticus?

Epilepsia

Volumn 48, Issue SUPPL. 8, 2007, Pages 52-55

  Rossetti, Andrea O ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Anesthetic agents; Coma induction; Refractory status epilepticus; Treatment

Indexed keywords

ANESTHETIC AGENT; BENZODIAZEPINE; MIDAZOLAM; PENTOBARBITAL; PROPOFOL; THIOPENTAL;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG WITHDRAWAL; EPILEPTIC STATE; GRAND MAL SEIZURE; HUMAN; LOADING DRUG DOSE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TACHYPHYLAXIS; TREATMENT DURATION;

ANESTHETICS; ANESTHETICS, INTRAVENOUS; ANTICONVULSANTS; BARBITURATES; COMA; ELECTROENCEPHALOGRAPHY; FORECASTING; HUMANS; MIDAZOLAM; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPOFOL; STATUS EPILEPTICUS;

EID: 35748982406     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01350.x     Document Type: Conference Paper

References (42)

1. Aminoff MJ 1998) Do nonconvulsive seizures damage the brain?-No. Arch Neurol 55 : 119 120.
2. Bayliff CD, Schwartz ML, Hardy BG 1985) Pharmacokinetics of high-dose pentobarbital in severe head trauma. Clin Pharmacol Ther 38 : 457 461.
3. Charlesworth P, Jacobson I, Richards CD 1996) Pentobarbitone modulation of NMDA receptors in neurons isolated from the rat olfactory brain. Br J Pharmacol 1995 116 : 3005 3013. Erratum in Brit J Pharmacol 117:1370.
4. Chen JWY, Wasterlain CG 2006) Status epilepticus: pathophysiology and management in adults. Lancet Neurol 5 : 246 256.
5. Claassen J, Hirsch LJ, Bates JE, Thompson TB, Mayer SA 2001) Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 57 : 1036 1142.
6. Claassen J, Hirsch LJ, Emerson RG, Mayer SA 2002) Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 43 : 146 153.
7. Claassen J, Hirsch LJ, Mayer SA 2003) Treatment of status epilepticus: a survey of neurologists. J Neurol Sci 211 : 37 41.
8. Cordato DJ, Mather LE, Gross AS, Herkes GK 1999) Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy. Anesthesiology 91 : 1693 1702.
9. Fountain NB, Lothman EW 1995) Pathophysiology of status epilepticus. J Clin Neurophysiol 12 : 326 342.
10. Holtkamp M, Masuhr F, Harms L, Einhaupl KM, Meierkord H, Buchheim K 2003) The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatr 74 : 1095 1099.
11. Holtkamp M, Othman J, Buchheim K, Meierkord H 2005) Predictors of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatr 76 : 534 539.
12. Holtkamp M. (2007) The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 20 : 188 193.
13. Jevtovic-Todorovic V, Wozniak DF, Powell S, Olney JW 2001) Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulated/retrosplenial cortex. Brain Res 913 : 185 189.
14. Kress HG, Segmueller R 1987) Intravenous anesthetics and human neutrophil granulocyte motility in vitro. Anaesthesist 26 : 356 361.
15. Krishnamurthy KB, Drislane FW 1996) Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 37 : 863 867.
16. Krishnamurthy KB, Drislane FW 1999) Depth of EEG suppression and outcome in barbiturate anesthetic treatment of status epilepticus. Epilepsia 40 : 759 762.
17. Leppert D, Stöckli HR, Fuhr P, pour la conférence de consensus sur l'état de mal épileptique des hôpitaux du Nord-Ouest suisse 2005) Directives pour le traitement de l'état de mal épileptique. Schweiz Aerztezeitung 86. http://www.saez.ch/ status_epilepticus_f.pdf
18. Lowenstein DH, Alldredge BK 1998) Status epilepticus. N Engl J Med 388 : 970 976.
19. Marik PE 2004) Propofol: therapeutic indications and side-effects. Curr Pharm Des 10 : 3639 3649.
20. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF 2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 59 : 205 210.
21. Minicucci F, Muscas G, Perucca E, Capovilla G, Vigevano F, Tinuper P 2006) Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia 47 (Suppl. 5 9 15.
22. Mirsattari SM, Sharpe MD, Young GB 2004) Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 61 : 1254 1259.
23. Naritoku DK, Sinha S 2000) Prolongation of midazolam half-life after sustained infusion for status epilepticus. Neurology 1366 1368.
24. Orser BA, Bertlik M, Wang LY, MacDonald JF 1995) Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-aspartate subtype glutamate receptor in cultured hippocampal neurons. Br J Pharmacol 116 : 1761 1768.
25. Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E 2002) High-doses thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 59 : 1249 1251.
26. Parviainen I, Uusaro A, Kalviainen R, Mervaala E, Ruokonen E 2006) Propofol in the treatment of refractory status epilepticus. Intensive Care Med 32 : 1075 1079.
27. Prasad A, Worrall BB, Bertram EH, Bleck TP 2001) Propofol and Midazolam in treatment of refractory status epilepticus. Epilepsia 42 : 380 386.
28. Rogawski MA, Loscher W 2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 : 553 564.
29. Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J 2004) Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 45 : 757 763.
30. Rossetti AO, Logroscino G, Bromfield EB 2005) Refractory status epilepticus. Effect of treatment aggressiveness on prognosis. Arch Neurol 62 : 1698 1702.
31. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB 2006) Prognosis of status epilepticus: role of etiology, age and consciousness impairment at presentation. J Neurol Neurosurg Psychiatr 77 : 611 615.
32. Sheth RD, Gidal BE 1998) Refractory status epilepticus: response to ketamine. Neurology 51 : 1765 1766.
33. Shorvon S. (2001) The management of status epilepticus. J Neurol Neurosurg Psychiatr 70 (Suppl. II i22 27.
34. Stecker MM, Kramer TH, Raps EC, O'Meeghan R, Dulaney E, Skaar DJ 1998) Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 39 : 18 26.
35. Treiman DM, Walton NY, Collins JF 1999) Treatment of status epilepticus if first drug fails. Epilepsia 40 (Suppl. 7 243 Abstract)
36. van Ness PC 1990) Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 31 : 61 67.
37. van Rijckevorsel K, Boon P, Hauman H, et al 2006) Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 106 : 117 124.
38. Vasile B, Rasulo F, Candiani A, Latronico N 2003) The pathophysiology of the propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29 : 1417 1425.
39. Wessen A, Persson PM, Nilsson A, Hartvig P 1994) Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade. J Clin Anaesthesiol 6 : 193 198.
40. Young GB, Jordan KG 1998) Do nonconvulsive seizures damage the brain?-Yes. Arch Neurol 55 : 117 119.
41. Zarovnaya EL, Jobst BC, Harris BT 2007) Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia 48 : 1002 1006.
42. Zhan RZ, Qi S, Wu C, Fujihara H, Taga K, Shimoji K 2001) Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition. Crit Care Med 29 : 808 813.